News
Definitive Healthcare Q1 Review: Revenue Slumps, Structural Issues Surface, And A SELL Rating Sticks
Definitive Healthcare faces structural revenue decline, weak retention, and competitive pressure, raising long-term concerns.
Health-care companies fell, but not by as much as the broad market, as a conflict between Israel and Iran was set to escalate. Investors bought into safe havens, including gold futures and some health ...
Deutsche Bank downgraded Intuitive Surgical, Inc. amid rising competition and remanufactured tools. Click for my ISRG stock ...
StockStory.org on MSN1d
3 Healthcare Stocks with Questionable FundamentalsPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...
1d
Zacks Investment Research on MSNAre Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Astellas Pharma Inc. (ALPMY) is a stock that can certainly grab ...
Welcome to the Apollo Hospital Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...
Health-care companies were more or less flat as traders sought out defensive sectors in light of doubts about a trade deal. Pennsylvania lawmakers took a step toward enacting restrictions on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results